Sulfatide antibody-mediated neuropathy: an analysis of clinical characteristics and immunotherapeutic responses
Sulfatide antibodies may attack peripheral nerves and the brainstem. The prognosis is relatively good for most patients by immunotherapy. Patients with sole sulfatide antibody exhibited more severe symptoms and electrophysiological issues but responded better to treatment.
Authors
- Meijuan Zhang (ORCID: https://orcid.org/0000-0002-5375-5349)
- Fangyu Zhou (ORCID: https://orcid.org/0000-0002-5121-133X)
- Yun Xu (ORCID: https://orcid.org/0000-0001-5288-0319)
- Zhuo Liu (ORCID: https://orcid.org/0000-0001-9202-0516)
- Qi Zheng (ORCID: https://orcid.org/0000-0003-1431-4724)
- Jinglong Hu
- Wenqian Gao
Institutions
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1080/01616412.2025.2509154
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China